Sisältölaatikko

Teksti tai HTML-koodi

Contact (not visiting address)

Innovamedical UK Ltd.
c/oDerek Rothera & Company LLP
Units 15 &16, 7 Wenlock Road, London, N1 7SL
phone: 07780 563667
e-mail:
info@innovamedical.co.uk

Scientific Publications

 

Use of Suprathel(®) for partial thickness burns in children.

Lyndsey Highton, Christopher Wallace, Mamta Shah
        Department of Burns and Plastic Surgery, Central Manchester University Hospital NHS Foundation Trust, Oxford Road, Manchester M13 9WL, United Kingdom.   
Burns: journal of the International Society for Burn Injuries (impact factor:        1.95).                 06/2012;                 DOI:10.1016/j.burns.2012.05.005               
 
 

"Suprathel®—An innovative, resorbable skin substitute for the treatment of burn victims"
Burns, Volume 33, Issue 2, March 2007, Pages 221-229
C. Uhlig, M. Rapp, B. Hartmann, H. Hierlemann, H. Planck and K.-K. Dittel

 

"Suprathel®, a new skin substitute, in the management of donor sites of split-thickness skin grafts: Results of a clinical study"
Burns, Volume 33, Issue 7, November 2007, Pages 850-854
H. Schwarze, M. Küntscher, C. Uhlig, H. Hierlemann, L. Prantl, N. Noack and B. Hartmann

 

"Suprathel is better than Mepilex Transfer in the treatment of split thickness skin graft donor sites"

Presentation National Surgical Congress Finland November 2009

Ilkka Kaartinen and Hannu Kuokkanen, Dep of Plastic surgery, Tampere University Hospital Finland

"Comparison of Suprathel® and allograft skin in the treatment of a severe case of toxic epidermal necrolysis" 

Andrew J. Lindford (a), Ilkka S. Kaartinen (a), Susanna Virolainen (b), Jyrki Vuola (a)

(a) Department of Plastic Surgery, Helsinki University Hospital, Helsinki, Finland  

(b) Department of Pathology, Haartman Institute, Helsinki University Hospital, Helsinki, Finland

Lindford AJ, et al. Comparison of Suprathel1 and allograft skin in the treatment of a severe case of toxic epidermal necrolysis.Burns(2011),doi:10.1016/j.burns.2011.07.01